Navigation Links
V. Suzanne Klimberg, M.D. Appointed Medical Director of Ascendant Diagnostics™

Fayetteville, Arkansas (PRWEB) September 24, 2013

Omid Moghadam, Chairman and CEO of Ascendant Diagnostics, recently named V. Suzanne Klimberg, M.D, to the position of Medical Director. Ascendant Diagnostics is in the process of developing the company’s first product, MelodyDx™, a pain-free, low-cost screening test that can detect the presence of early-stage breast cancer using the protein profile of a person’s tears.

With many distinguished achievements to her credit, Dr. Klimberg (in collaboration with Larry Suva, Ph.D.) discovered breast cancer protein patterns in tears and is the co-inventor of MelodyDx™. “Early detection of breast cancer is critical for saving lives, and we hope this technology will help us reach even more women for early screening,” says Dr. Klimberg. “While a mammogram is an essential screening tool, we know that many women are reluctant to get mammograms for a variety of reasons, and they’ll either delay getting a mammogram or avoid it altogether.”

Dr. Klimberg, a practicing breast surgeon, is the director of the Breast Cancer Program at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute in Little Rock, Ark. She holds the Muriel Balsam Kohn Chair in Breast Surgical Oncology and is a professor of surgery and pathology at UAMS. Since 1993, Dr. Klimberg has been director of Fellowship in Diseases of the Breast at the UAMS Cancer Institute and John L. McClellan VA Hospital.

Research has been an important component of Dr. Klimberg’s career and she has consistently received highly sought after and competitive funding awards from national organizations including: National Institutes of Health, American Cancer Society and Susan G. Komen Foundation. She holds a number of elected offices and appointments including President, Society of Surgical Oncology, Board Member, American Cancer Society and Board Member, American Society of Breast Surgeons. Dr. Klimberg has received numerous awards and honors, has produced more than 200 publications and chapters and serves on editorial boards for several professional journals.

“Dr. Klimberg will be leading clinical validation studies as well as educating health care providers about MelodyDx,” explains Moghadam. “Dr. Klimberg has made significant contributions to improving outcomes for women with breast cancer and we feel fortunate to have her helping us bring our diagnostic test to market.”

Ascendant Diagnostics’ vision is to greatly increase the accuracy of diagnostics of diseases, enable detection of disease at the earliest possible stage, and improve patient compliance through the use of non-invasive, pain-free diagnostic tools. The company's first product, MelodyDx™, is a patent pending, non-invasive, biomarker panel for the detection of breast cancer, which detects differences in proteins present in human tears. The goal for MelodyDx™ is to increase breast cancer detection at earlier stages while at the same time reducing unnecessary exposure to radiation and painful biopsy procedures. Ascendant Diagnostics, LLC is a VIC Technology Venture Development™ portfolio company.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
2. Dr. Gil Ben-Menachem appointed Chief Executive Officer of OphthaliX Inc.
3. Infotrieve Appointed to EContent 100
4. Janet Kreizman Appointed Chief Executive Officer of AACC
5. Gregory Raupp Appointed Director of MacroTechnology Works at Arizona State University to Advance Flexible Electronics and Manufacturing
6. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
7. ClearPath Workforce Management CEO Appointed Co-chair of Northern California Leadership Forum for Woman Owned Business Alliance
8. Ondine Biomedical CEO Carolyn Cross Appointed Treasurer of International Photodynamic Association
9. Quorum Review IRB Board Chair Appointed to SACHRP
10. James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
11. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
Breaking Biology News(10 mins):